1059. In vitro Activity of Exebacase (CF-301) against Staphylococcus aureus Causing Bacteremia in the United States, Including Multidrug-resistant Subsets

BACKGROUND: Exebacase (CF-301) is a lysin (peptidoglycan hydrolase enzyme) with anti-staphylococcal activity. CF-301 is in Phase 3 of clinical development for the treatment of Staphylococcus aureus (SA) bacteremia (SAB), including right-sided infective endocarditis (IE), used in addition to standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Lindley, Jill, Gurung, Nabina, Castanheira, Mariana, Schuch, Ray, Ambler, Jane E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644533/
http://dx.doi.org/10.1093/ofid/ofab466.1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644533/
http://dx.doi.org/10.1093/ofid/ofab466.1253

Ejemplares similares